Back

Results - Announcements

Sales rise 58.95% to Rs 402.02 crore

Cohance Lifesciences consolidated net profit declines 21.29% in the March 2025 quarter

29-May-2025, 07:32
Net profit of Cohance Lifesciences declined 21.29% to Rs 42.01 crore in the quarter ended March 2025 as against Rs 53.37 crore during the previous quarter ended March 2024. Sales rose 58.95% to Rs 402.02 crore in the quarter ended March 2025 as against Rs 252.93 crore during the previous quarter ended March 2024.

For the full year,net profit declined 10.79% to Rs 267.87 crore in the year ended March 2025 as against Rs 300.28 crore during the previous year ended March 2024. Sales rose 13.91% to Rs 1197.58 crore in the year ended March 2025 as against Rs 1051.35 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	402.02	252.93	59	1197.58	1051.35	14
OPM %	18.30	29.00	-	31.33	38.60	-
PBDT	78.38	88.10	-11	421.41	460.27	-8
PBT	51.60	70.85	-27	343.92	405.67	-15
NP	42.01	53.37	-21	267.87	300.28	-11